Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020
Introduction: Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated pork, but has also been reported to be transmitted through blood transfusion. Although most HEV infections, including those via...
Uložené v:
| Vydané v: | Viruses Ročník 16; číslo 5; s. 744 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Switzerland
MDPI AG
01.05.2024
|
| Predmet: | |
| ISSN: | 1999-4915, 1999-4915 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Introduction: Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated pork, but has also been reported to be transmitted through blood transfusion. Although most HEV infections, including those via blood products, are usually self-limiting, they may become chronic in immunocompromised persons. It is thus essential to identify HEV-infected blood donations to prevent transmission to vulnerable recipients. Aims: Prior to the decision whether to introduce HEV RNA screening for all Swiss blood donations, a 2-year nationwide prevalence study was conducted. Methods: All blood donations were screened in pools of 12–24 samples at five regional blood donation services, and HEV RNA-positive pools were subsequently resolved to the individual donation index donation (X). The viral load, HEV IgG and IgM serology, and HEV genotype were determined. Follow-up investigations were conducted on future control donations (X + 1) and previous archived donations of the donor (X − 1) where available. Results: Between October 2018 and September 2020, 541,349 blood donations were screened and 125 confirmed positive donations were identified (prevalence 1:4331 donations). At the time of blood donation, the HEV RNA-positive individuals were symptom-free. The median viral load was 554 IU/mL (range: 2.01–2,500,000 IU/mL). Men (88; 70%) were more frequently infected than women (37; 30%), as compared with the sex distribution in the Swiss donor population (57% male/43% female, p < 0.01). Of the 106 genotyped cases (85%), all belonged to genotype 3. Two HEV sub-genotypes predominated; 3h3 (formerly 3s) and 3c. The remaining sub-genotypes are all known to circulate in Europe. Five 3ra genotypes were identified, this being a variant associated with rabbits. In total, 85 (68%) X donations were negative for HEV IgM and IgG. The remaining 40 (32%) were positive for HEV IgG and/or IgM, and consistent with an active infection. We found no markers of previous HEV in 87 of the 89 available and analyzed archive samples (X − 1). Two donors were HEV IgG-positive in the X − 1 donation suggesting insufficient immunity to prevent HEV reinfection. Time of collection of the 90 (72%) analyzed X + 1 donations varied between 2.9 and 101.9 weeks (median of 35 weeks) after X donation. As expected, none of those tested were positive for HEV RNA. Most donors (89; 99%) were positive for anti-HEV lgG/lgM (i.e., seroconversion). HEV lgM-positivity (23; 26%) indicates an often-long persistence of lgM antibodies post-HEV infection. Conclusion: The data collected during the first year of the study provided the basis for the decision to establish mandatory HEV RNA universal screening of all Swiss blood donations in minipools, a vital step in providing safer blood for all recipients, especially those who are immunosuppressed. |
|---|---|
| AbstractList | Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated pork, but has also been reported to be transmitted through blood transfusion. Although most HEV infections, including those via blood products, are usually self-limiting, they may become chronic in immunocompromised persons. It is thus essential to identify HEV-infected blood donations to prevent transmission to vulnerable recipients.INTRODUCTIONHepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated pork, but has also been reported to be transmitted through blood transfusion. Although most HEV infections, including those via blood products, are usually self-limiting, they may become chronic in immunocompromised persons. It is thus essential to identify HEV-infected blood donations to prevent transmission to vulnerable recipients.Prior to the decision whether to introduce HEV RNA screening for all Swiss blood donations, a 2-year nationwide prevalence study was conducted.AIMSPrior to the decision whether to introduce HEV RNA screening for all Swiss blood donations, a 2-year nationwide prevalence study was conducted.All blood donations were screened in pools of 12-24 samples at five regional blood donation services, and HEV RNA-positive pools were subsequently resolved to the individual donation index donation (X). The viral load, HEV IgG and IgM serology, and HEV genotype were determined. Follow-up investigations were conducted on future control donations (X + 1) and previous archived donations of the donor (X - 1) where available.METHODSAll blood donations were screened in pools of 12-24 samples at five regional blood donation services, and HEV RNA-positive pools were subsequently resolved to the individual donation index donation (X). The viral load, HEV IgG and IgM serology, and HEV genotype were determined. Follow-up investigations were conducted on future control donations (X + 1) and previous archived donations of the donor (X - 1) where available.Between October 2018 and September 2020, 541,349 blood donations were screened and 125 confirmed positive donations were identified (prevalence 1:4331 donations). At the time of blood donation, the HEV RNA-positive individuals were symptom-free. The median viral load was 554 IU/mL (range: 2.01-2,500,000 IU/mL). Men (88; 70%) were more frequently infected than women (37; 30%), as compared with the sex distribution in the Swiss donor population (57% male/43% female, p < 0.01). Of the 106 genotyped cases (85%), all belonged to genotype 3. Two HEV sub-genotypes predominated; 3h3 (formerly 3s) and 3c. The remaining sub-genotypes are all known to circulate in Europe. Five 3ra genotypes were identified, this being a variant associated with rabbits. In total, 85 (68%) X donations were negative for HEV IgM and IgG. The remaining 40 (32%) were positive for HEV IgG and/or IgM, and consistent with an active infection. We found no markers of previous HEV in 87 of the 89 available and analyzed archive samples (X - 1). Two donors were HEV IgG-positive in the X - 1 donation suggesting insufficient immunity to prevent HEV reinfection. Time of collection of the 90 (72%) analyzed X + 1 donations varied between 2.9 and 101.9 weeks (median of 35 weeks) after X donation. As expected, none of those tested were positive for HEV RNA. Most donors (89; 99%) were positive for anti-HEV lgG/lgM (i.e., seroconversion). HEV lgM-positivity (23; 26%) indicates an often-long persistence of lgM antibodies post-HEV infection.RESULTSBetween October 2018 and September 2020, 541,349 blood donations were screened and 125 confirmed positive donations were identified (prevalence 1:4331 donations). At the time of blood donation, the HEV RNA-positive individuals were symptom-free. The median viral load was 554 IU/mL (range: 2.01-2,500,000 IU/mL). Men (88; 70%) were more frequently infected than women (37; 30%), as compared with the sex distribution in the Swiss donor population (57% male/43% female, p < 0.01). Of the 106 genotyped cases (85%), all belonged to genotype 3. Two HEV sub-genotypes predominated; 3h3 (formerly 3s) and 3c. The remaining sub-genotypes are all known to circulate in Europe. Five 3ra genotypes were identified, this being a variant associated with rabbits. In total, 85 (68%) X donations were negative for HEV IgM and IgG. The remaining 40 (32%) were positive for HEV IgG and/or IgM, and consistent with an active infection. We found no markers of previous HEV in 87 of the 89 available and analyzed archive samples (X - 1). Two donors were HEV IgG-positive in the X - 1 donation suggesting insufficient immunity to prevent HEV reinfection. Time of collection of the 90 (72%) analyzed X + 1 donations varied between 2.9 and 101.9 weeks (median of 35 weeks) after X donation. As expected, none of those tested were positive for HEV RNA. Most donors (89; 99%) were positive for anti-HEV lgG/lgM (i.e., seroconversion). HEV lgM-positivity (23; 26%) indicates an often-long persistence of lgM antibodies post-HEV infection.The data collected during the first year of the study provided the basis for the decision to establish mandatory HEV RNA universal screening of all Swiss blood donations in minipools, a vital step in providing safer blood for all recipients, especially those who are immunosuppressed.CONCLUSIONThe data collected during the first year of the study provided the basis for the decision to establish mandatory HEV RNA universal screening of all Swiss blood donations in minipools, a vital step in providing safer blood for all recipients, especially those who are immunosuppressed. Introduction: Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated pork, but has also been reported to be transmitted through blood transfusion. Although most HEV infections, including those via blood products, are usually self-limiting, they may become chronic in immunocompromised persons. It is thus essential to identify HEV-infected blood donations to prevent transmission to vulnerable recipients. Aims: Prior to the decision whether to introduce HEV RNA screening for all Swiss blood donations, a 2-year nationwide prevalence study was conducted. Methods: All blood donations were screened in pools of 12–24 samples at five regional blood donation services, and HEV RNA-positive pools were subsequently resolved to the individual donation index donation (X). The viral load, HEV IgG and IgM serology, and HEV genotype were determined. Follow-up investigations were conducted on future control donations (X + 1) and previous archived donations of the donor (X − 1) where available. Results: Between October 2018 and September 2020, 541,349 blood donations were screened and 125 confirmed positive donations were identified (prevalence 1:4331 donations). At the time of blood donation, the HEV RNA-positive individuals were symptom-free. The median viral load was 554 IU/mL (range: 2.01–2,500,000 IU/mL). Men (88; 70%) were more frequently infected than women (37; 30%), as compared with the sex distribution in the Swiss donor population (57% male/43% female, p < 0.01). Of the 106 genotyped cases (85%), all belonged to genotype 3. Two HEV sub-genotypes predominated; 3h3 (formerly 3s) and 3c. The remaining sub-genotypes are all known to circulate in Europe. Five 3ra genotypes were identified, this being a variant associated with rabbits. In total, 85 (68%) X donations were negative for HEV IgM and IgG. The remaining 40 (32%) were positive for HEV IgG and/or IgM, and consistent with an active infection. We found no markers of previous HEV in 87 of the 89 available and analyzed archive samples (X − 1). Two donors were HEV IgG-positive in the X − 1 donation suggesting insufficient immunity to prevent HEV reinfection. Time of collection of the 90 (72%) analyzed X + 1 donations varied between 2.9 and 101.9 weeks (median of 35 weeks) after X donation. As expected, none of those tested were positive for HEV RNA. Most donors (89; 99%) were positive for anti-HEV lgG/lgM (i.e., seroconversion). HEV lgM-positivity (23; 26%) indicates an often-long persistence of lgM antibodies post-HEV infection. Conclusion: The data collected during the first year of the study provided the basis for the decision to establish mandatory HEV RNA universal screening of all Swiss blood donations in minipools, a vital step in providing safer blood for all recipients, especially those who are immunosuppressed. Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated pork, but has also been reported to be transmitted through blood transfusion. Although most HEV infections, including those via blood products, are usually self-limiting, they may become chronic in immunocompromised persons. It is thus essential to identify HEV-infected blood donations to prevent transmission to vulnerable recipients. Prior to the decision whether to introduce HEV RNA screening for all Swiss blood donations, a 2-year nationwide prevalence study was conducted. All blood donations were screened in pools of 12-24 samples at five regional blood donation services, and HEV RNA-positive pools were subsequently resolved to the individual donation index donation (X). The viral load, HEV IgG and IgM serology, and HEV genotype were determined. Follow-up investigations were conducted on future control donations (X + 1) and previous archived donations of the donor (X - 1) where available. Between October 2018 and September 2020, 541,349 blood donations were screened and 125 confirmed positive donations were identified (prevalence 1:4331 donations). At the time of blood donation, the HEV RNA-positive individuals were symptom-free. The median viral load was 554 IU/mL (range: 2.01-2,500,000 IU/mL). Men (88; 70%) were more frequently infected than women (37; 30%), as compared with the sex distribution in the Swiss donor population (57% male/43% female, < 0.01). Of the 106 genotyped cases (85%), all belonged to genotype 3. Two HEV sub-genotypes predominated; 3h3 (formerly 3s) and 3c. The remaining sub-genotypes are all known to circulate in Europe. Five 3ra genotypes were identified, this being a variant associated with rabbits. In total, 85 (68%) X donations were negative for HEV IgM and IgG. The remaining 40 (32%) were positive for HEV IgG and/or IgM, and consistent with an active infection. We found no markers of previous HEV in 87 of the 89 available and analyzed archive samples (X - 1). Two donors were HEV IgG-positive in the X - 1 donation suggesting insufficient immunity to prevent HEV reinfection. Time of collection of the 90 (72%) analyzed X + 1 donations varied between 2.9 and 101.9 weeks (median of 35 weeks) after X donation. As expected, none of those tested were positive for HEV RNA. Most donors (89; 99%) were positive for anti-HEV lgG/lgM (i.e., seroconversion). HEV lgM-positivity (23; 26%) indicates an often-long persistence of lgM antibodies post-HEV infection. The data collected during the first year of the study provided the basis for the decision to establish mandatory HEV RNA universal screening of all Swiss blood donations in minipools, a vital step in providing safer blood for all recipients, especially those who are immunosuppressed. |
| Audience | Academic |
| Author | Amar EL Dusouqui, Soraya Gottschalk, Jochen Widmer, Nadja Mattle-Greminger, Maja Niederhauser, Christoph Gowland, Peter Frey, Beat M. |
| Author_xml | – sequence: 1 givenname: Christoph orcidid: 0000-0003-3142-7616 surname: Niederhauser fullname: Niederhauser, Christoph – sequence: 2 givenname: Peter surname: Gowland fullname: Gowland, Peter – sequence: 3 givenname: Nadja surname: Widmer fullname: Widmer, Nadja – sequence: 4 givenname: Soraya surname: Amar EL Dusouqui fullname: Amar EL Dusouqui, Soraya – sequence: 5 givenname: Maja surname: Mattle-Greminger fullname: Mattle-Greminger, Maja – sequence: 6 givenname: Jochen surname: Gottschalk fullname: Gottschalk, Jochen – sequence: 7 givenname: Beat M. orcidid: 0000-0002-2514-8621 surname: Frey fullname: Frey, Beat M. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38793625$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkstuUzEQhi1URC-w4AWQJTawSOu7j5ehFBqpEojb1vLxpXJ0Ygf7nCJ2vANvyJPgNCGCqhLyYqzRN_-MZv5jcJBy8gA8xeiUUoXObrBAHEnGHoAjrJSaMYX5wV__Q3Bc6xIhIRSSj8Ah7aSigvAj8OF98Tdm8Ml6mAOc22n08NKvzRjHWOEF_BLLVOEiBW_HmFOFMcGP32Kt8NWQs4Ovc8qlQoJw9-vHT4IIegweBjNU_2QXT8DnNxefzi9nV-_eLs7nVzPLMRtnHVFMSkctV1wxHBjixCmDBEfUIG6wC5QYxn0IxirmuKSCM4IkDn0fZKAnYLHVddks9brElSnfdTZR3yZyudamjNEOXlMZLO0tt70kzGHagifeOIOslTTgpvViq7Uu-evk66hXsVo_DCb5PFVNMaeCIiLZ_1EkEO0wY7yhz--gyzyV1JbSKK6kIuJWcEddtzvomEIei7EbUT2Xigvc2naNOr2Has_5VbTNDyG2_D8Fz3bNp37l3X5Bf27fgJdbwJZca_Fhj2CkN77Se1819uwOa-NoNoZoU8ThnorfDFzI2Q |
| CitedBy_id | crossref_primary_10_1093_trstmh_traf073 crossref_primary_10_1007_s00430_025_00838_y crossref_primary_10_3390_pathogens13100911 |
| Cites_doi | 10.1111/ene.16030 10.1111/trf.12929 10.1093/molbev/msy096 10.1111/vox.12719 10.1016/j.jhep.2022.04.015 10.3201/eid2307.170318 10.1002/hep.28436 10.3390/v8080222 10.1111/trf.14531 10.3389/fmed.2018.00005 10.1111/trf.13402 10.3201/eid2301.160923 10.3390/v14122611 10.1016/j.jcv.2019.09.004 10.1016/j.jcv.2015.06.103 10.3201/eid2011.140516 10.3390/ani11113177 10.3201/eid2612.191482 10.1017/S0950268817001388 10.1111/vox.12056 10.3390/v11070617 10.1111/trf.13700 10.1111/trf.15807 10.1016/j.tracli.2023.01.005 10.1016/j.ijfoodmicro.2017.06.029 10.1111/j.1537-2995.2004.03300.x 10.1159/000499121 10.1016/S0140-6736(14)61034-5 10.3390/v13071265 10.1056/NEJMoa0706992 10.1016/j.jhep.2012.08.001 10.1097/TP.0b013e318296c9f7 10.1016/j.jhep.2018.03.005 10.3201/eid1304.061387 10.1111/j.1423-0410.2011.01583.x 10.1016/j.jhep.2018.02.031 10.1099/jgv.0.001778 10.1111/trf.13498 10.1111/tme.12405 10.1093/cid/ciz953 10.1073/pnas.94.18.9860 10.1111/trf.16700 10.7326/L15-0502 10.1111/jvh.13682 10.1016/j.jhep.2019.01.025 10.3201/eid2801.211466 10.1002/rmv.1987 10.1099/jgv.0.001435 10.1111/trf.13757 10.1182/blood-2013-09-524348 10.1128/JCM.01119-12 10.1016/j.jcv.2013.08.022 10.3201/eid2809.220487 10.1111/trf.15058 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2024 MDPI AG 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: COPYRIGHT 2024 MDPI AG – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 7S9 L.6 DOA |
| DOI | 10.3390/v16050744 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef Publicly Available Content Database AGRICOLA |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1999-4915 |
| ExternalDocumentID | oai_doaj_org_article_37fc3bc5cb724d13b72e2eada0cc73f1 A795610278 38793625 10_3390_v16050744 |
| Genre | Journal Article |
| GeographicLocations | Switzerland France United Kingdom Germany United Kingdom--UK Ireland Europe Japan Spain |
| GeographicLocations_xml | – name: Switzerland – name: United Kingdom – name: France – name: Germany – name: Ireland – name: United Kingdom--UK – name: Japan – name: Spain – name: Europe |
| GrantInformation_xml | – fundername: Humanitarian Foundation of the Swiss Red Cross grantid: 244 |
| GroupedDBID | --- 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACUHS AFFHD AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK E3Z EBD ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M48 M7P MODMG M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO RPM TR2 TUS UKHRP ALIPV CGR CUY CVF ECM EIF NPM 3V. 7U9 7XB 8FK AZQEC DWQXO ESTFP GNUQQ H94 K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7S9 L.6 |
| ID | FETCH-LOGICAL-c514t-829477d3c595941f4052d9a06503a05a1df32a45effac94d5736542071fbbf7f3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001231315700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1999-4915 |
| IngestDate | Fri Oct 03 12:43:41 EDT 2025 Sat Sep 27 21:26:38 EDT 2025 Mon Sep 08 06:52:45 EDT 2025 Tue Oct 07 07:07:58 EDT 2025 Sat Nov 29 14:02:58 EST 2025 Mon Nov 24 15:41:56 EST 2025 Mon Jul 21 06:04:09 EDT 2025 Tue Nov 18 22:07:16 EST 2025 Sat Nov 29 07:15:06 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | blood donors hepatitis E virus phylogenetic analysis surveillance universal blood donor screening genotype zoonotic infection Switzerland |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c514t-829477d3c595941f4052d9a06503a05a1df32a45effac94d5736542071fbbf7f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-3142-7616 0000-0002-2514-8621 |
| OpenAccessLink | https://doaj.org/article/37fc3bc5cb724d13b72e2eada0cc73f1 |
| PMID | 38793625 |
| PQID | 3059792674 |
| PQPubID | 2032319 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_37fc3bc5cb724d13b72e2eada0cc73f1 proquest_miscellaneous_3153630274 proquest_miscellaneous_3060381445 proquest_journals_3059792674 gale_infotracmisc_A795610278 gale_infotracacademiconefile_A795610278 pubmed_primary_38793625 crossref_primary_10_3390_v16050744 crossref_citationtrail_10_3390_v16050744 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-05-01 |
| PublicationDateYYYYMMDD | 2024-05-01 |
| PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Viruses |
| PublicationTitleAlternate | Viruses |
| PublicationYear | 2024 |
| Publisher | MDPI AG |
| Publisher_xml | – name: MDPI AG |
| References | Bes (ref_23) 2022; 28 Laperche (ref_44) 2023; 21 Baylis (ref_26) 2012; 103 Niederhauser (ref_27) 2018; 23 ref_58 Kamar (ref_18) 2008; 358 ref_57 Abravanel (ref_62) 2017; 23 Grabarczyk (ref_42) 2018; 58 ref_56 Healy (ref_43) 2022; 29 Boxman (ref_28) 2017; 257 Baylis (ref_61) 2022; 77 ref_52 Hewitt (ref_4) 2014; 384 Mansuy (ref_34) 2016; 63 Hogema (ref_37) 2016; 56 Coilly (ref_13) 2013; 96 Mallet (ref_15) 2016; 164 Harritshoj (ref_25) 2016; 56 Domanovic (ref_22) 2017; 22 Tedder (ref_47) 2016; 56 Huzly (ref_16) 2014; 19 Boland (ref_49) 2016; 56 Ankcorn (ref_2) 2017; 27 Matsubayashi (ref_10) 2004; 44 ref_66 Sahli (ref_63) 2019; 70 Kamar (ref_8) 2020; 71 Slot (ref_36) 2013; 18 Ripellino (ref_7) 2023; 31 Hauser (ref_14) 2014; 123 Izopet (ref_59) 2019; 120 Dalton (ref_5) 2018; 68 Gallian (ref_35) 2014; 20 Westholter (ref_33) 2018; 69 Kamp (ref_55) 2018; 113 Vollmer (ref_41) 2012; 50 Sakata (ref_20) 2021; 61 Harvala (ref_40) 2019; 24 Fraga (ref_51) 2017; 38 Gorski (ref_24) 2023; 30 Meng (ref_29) 1997; 94 Said (ref_45) 2017; 145 Hickey (ref_50) 2016; 109 Nicot (ref_31) 2018; 28 Alfonsi (ref_64) 2018; 23 Cleland (ref_38) 2013; 105 Harvala (ref_46) 2022; 28 Kumar (ref_32) 2018; 35 Gallian (ref_17) 2020; 26 Sauleda (ref_39) 2015; 55 Forsythe (ref_54) 2023; 36 Smith (ref_30) 2020; 101 Loyrion (ref_53) 2017; 23 Ferey (ref_12) 2012; 57 Vollmer (ref_48) 2019; 59 Lanteri (ref_65) 2020; 60 Izopet (ref_60) 2015; 70 Dreier (ref_19) 2018; 5 ref_3 Colson (ref_11) 2007; 13 ref_9 Boland (ref_21) 2019; 46 Purdy (ref_1) 2022; 103 Verschuuren (ref_6) 2013; 58 |
| References_xml | – volume: 31 start-page: e16030 year: 2023 ident: ref_7 article-title: Neuropathies related to hepatitis E virus infection: A prospective, matched case-control study publication-title: Eur. J. Neurol. doi: 10.1111/ene.16030 – volume: 55 start-page: 972 year: 2015 ident: ref_39 article-title: Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain) publication-title: Transfusion doi: 10.1111/trf.12929 – volume: 35 start-page: 1547 year: 2018 ident: ref_32 article-title: MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msy096 – volume: 21 start-page: 110 year: 2023 ident: ref_44 article-title: Seven years (2015–2021) of blood donor screening for HEV-RNA in France: Lessons and perspectives publication-title: Blood Transfus. = Trasfus. Sangue – volume: 113 start-page: 811 year: 2018 ident: ref_55 article-title: Impact of hepatitis E virus testing on the safety of blood components in Germany—Results of a simulation study publication-title: Vox Sang. doi: 10.1111/vox.12719 – volume: 77 start-page: 870 year: 2022 ident: ref_61 article-title: Identification of rabbit hepatitis E virus (HEV) and novel HEV clade in Irish blood donors publication-title: J. Hepatol. doi: 10.1016/j.jhep.2022.04.015 – volume: 23 start-page: 1191 year: 2017 ident: ref_62 article-title: Rabbit Hepatitis E Virus Infections in Humans, France publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2307.170318 – volume: 63 start-page: 1145 year: 2016 ident: ref_34 article-title: A nationwide survey of hepatitis E viral infection in French blood donors publication-title: Hepatology doi: 10.1002/hep.28436 – volume: 19 start-page: 20812 year: 2014 ident: ref_16 article-title: Transfusion-transmitted hepatitis E in Germany, 2013 publication-title: Euro Surveill. Bull. Eur. Mal. Transm. = Eur. Commun. Dis. Bull. – ident: ref_9 doi: 10.3390/v8080222 – volume: 58 start-page: 1245 year: 2018 ident: ref_42 article-title: Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland publication-title: Transfusion doi: 10.1111/trf.14531 – volume: 5 start-page: 5 year: 2018 ident: ref_19 article-title: Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose publication-title: Front. Med. doi: 10.3389/fmed.2018.00005 – volume: 56 start-page: 722 year: 2016 ident: ref_37 article-title: Incidence and duration of hepatitis E virus infection in Dutch blood donors publication-title: Transfusion doi: 10.1111/trf.13402 – volume: 23 start-page: 146 year: 2017 ident: ref_53 article-title: Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2301.160923 – ident: ref_56 doi: 10.3390/v14122611 – volume: 120 start-page: 20 year: 2019 ident: ref_59 article-title: Hepatitis E virus infections in Europe publication-title: J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. doi: 10.1016/j.jcv.2019.09.004 – volume: 38 start-page: 619 year: 2017 ident: ref_51 article-title: Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland publication-title: Liver Int. Off. J. Int. Assoc. Study Liver – volume: 70 start-page: 39 year: 2015 ident: ref_60 article-title: Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France publication-title: J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. doi: 10.1016/j.jcv.2015.06.103 – volume: 20 start-page: 1914 year: 2014 ident: ref_35 article-title: Hepatitis E virus infections in blood donors, France publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2011.140516 – ident: ref_57 doi: 10.3390/ani11113177 – volume: 23 start-page: 1700616 year: 2018 ident: ref_27 article-title: Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016 publication-title: Euro Surveill. Bull. Eur. Mal. Transm. = Eur. Commun. Dis. Bull. – volume: 26 start-page: 2881 year: 2020 ident: ref_17 article-title: Risk for Hepatitis E Virus Transmission by Solvent/Detergent–Treated Plasma publication-title: Emerg. Infect. Dis. J. doi: 10.3201/eid2612.191482 – volume: 145 start-page: 2417 year: 2017 ident: ref_45 article-title: Pork products associated with human infection caused by an emerging phylotype of hepatitis E virus in England and Wales publication-title: Epidemiol. Infect. doi: 10.1017/S0950268817001388 – volume: 105 start-page: 283 year: 2013 ident: ref_38 article-title: Hepatitis E virus in Scottish blood donors publication-title: Vox Sang. doi: 10.1111/vox.12056 – ident: ref_3 doi: 10.3390/v11070617 – volume: 56 start-page: 2225 year: 2016 ident: ref_25 article-title: Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors publication-title: Transfusion doi: 10.1111/trf.13700 – volume: 60 start-page: 1319 year: 2020 ident: ref_65 article-title: Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light publication-title: Transfusion doi: 10.1111/trf.15807 – volume: 30 start-page: 244 year: 2023 ident: ref_24 article-title: Prevalence of HEV RNA in Croatian blood donors publication-title: Transfus. Clin. Biol. J. Soc. Fr. Transfus. Sang. doi: 10.1016/j.tracli.2023.01.005 – volume: 257 start-page: 225 year: 2017 ident: ref_28 article-title: Porcine blood used as ingredient in meat productions may serve as a vehicle for hepatitis E virus transmission publication-title: Int. J. Food Microbiol. doi: 10.1016/j.ijfoodmicro.2017.06.029 – ident: ref_52 – volume: 44 start-page: 934 year: 2004 ident: ref_10 article-title: Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan publication-title: Transfusion doi: 10.1111/j.1537-2995.2004.03300.x – volume: 46 start-page: 95 year: 2019 ident: ref_21 article-title: Blood Donor Screening for Hepatitis E Virus in the European Union publication-title: Transfus. Med. Hemotherapy doi: 10.1159/000499121 – ident: ref_66 – volume: 384 start-page: 1766 year: 2014 ident: ref_4 article-title: Hepatitis E virus in blood components: A prevalence and transmission study in southeast England publication-title: Lancet doi: 10.1016/S0140-6736(14)61034-5 – ident: ref_58 doi: 10.3390/v13071265 – volume: 358 start-page: 811 year: 2008 ident: ref_18 article-title: Hepatitis E virus and chronic hepatitis in organ-transplant recipients publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0706992 – volume: 109 start-page: 451 year: 2016 ident: ref_50 article-title: Hepatitis E Virus (HEV) Infection in Ireland publication-title: Ir. Med. J. – volume: 57 start-page: 1374 year: 2012 ident: ref_12 article-title: Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity publication-title: J. Hepatol. doi: 10.1016/j.jhep.2012.08.001 – volume: 96 start-page: e4 year: 2013 ident: ref_13 article-title: Posttransplantation hepatitis E: Transfusion-transmitted hepatitis rising from the ashes publication-title: Transplantation doi: 10.1097/TP.0b013e318296c9f7 – volume: 22 start-page: 30514 year: 2017 ident: ref_22 article-title: Hepatitis E and blood donation safety in selected European countries: A shift to screening? publication-title: Euro Surveill. Bull. Eur. Mal. Transm. = Eur. Commun. Dis. Bull. – volume: 68 start-page: 1256 year: 2018 ident: ref_5 article-title: EASL Clinical Practice Guidelines on hepatitis E virus infection publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.03.005 – volume: 23 start-page: 1700517 year: 2018 ident: ref_64 article-title: Hepatitis E in Italy: 5 years of national epidemiological, virological and environmental surveillance, 2012 to 2016 publication-title: Euro Surveill. Bull. Eur. Mal. Transm. = Eur. Commun. Dis. Bull. – volume: 13 start-page: 648 year: 2007 ident: ref_11 article-title: Transfusion-associated hepatitis E, France publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1304.061387 – volume: 103 start-page: 89 year: 2012 ident: ref_26 article-title: Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States publication-title: Vox Sang. doi: 10.1111/j.1423-0410.2011.01583.x – volume: 69 start-page: 36 year: 2018 ident: ref_33 article-title: HEV positive blood donations represent a relevant infection risk for immunosuppressed recipients publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.02.031 – volume: 103 start-page: 001778 year: 2022 ident: ref_1 article-title: ICTV Virus Taxonomy Profile: Hepeviridae 2022 publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001778 – volume: 56 start-page: 1529 year: 2016 ident: ref_47 article-title: Virology, serology, and demography of hepatitis E viremic blood donors in South East England publication-title: Transfusion doi: 10.1111/trf.13498 – volume: 27 start-page: 84 year: 2017 ident: ref_2 article-title: Hepatitis E: The current state of play publication-title: Transfus. Med. doi: 10.1111/tme.12405 – volume: 18 start-page: 20550 year: 2013 ident: ref_36 article-title: Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012 publication-title: Euro Surveill. Bull. Eur. Mal. Transm. = Eur. Commun. Dis. Bull. – volume: 71 start-page: 1204 year: 2020 ident: ref_8 article-title: Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study publication-title: Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. doi: 10.1093/cid/ciz953 – volume: 94 start-page: 9860 year: 1997 ident: ref_29 article-title: A novel virus in swine is closely related to the human hepatitis E virus publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.94.18.9860 – volume: 61 start-page: 3390 year: 2021 ident: ref_20 article-title: Trends in hepatitis E virus infection: Analyses of the long-term screening of blood donors in Hokkaido, Japan, 2005–2019 publication-title: Transfusion doi: 10.1111/trf.16700 – volume: 36 start-page: 11673 year: 2023 ident: ref_54 article-title: Impact of Hepatitis E Virus Screening in the UK Deceased Organ Donor Population publication-title: Transpl. Int. Off. J. Eur. Soc. Organ Transplant. – volume: 164 start-page: 851 year: 2016 ident: ref_15 article-title: Transmission of Hepatitis E Virus by Plasma Exchange: A Case Report publication-title: Ann. Intern. Med. doi: 10.7326/L15-0502 – volume: 29 start-page: 835 year: 2022 ident: ref_43 article-title: Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015-2018 publication-title: J. Viral Hepat. doi: 10.1111/jvh.13682 – volume: 70 start-page: 1023 year: 2019 ident: ref_63 article-title: Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.01.025 – volume: 28 start-page: 157 year: 2022 ident: ref_23 article-title: Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017–2020 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2801.211466 – volume: 24 start-page: 1800386 year: 2019 ident: ref_40 article-title: Hepatitis E virus in blood donors in England, 2016 to 2017: From selective to universal screening publication-title: Euro Surveill. Bull. Eur. Mal. Transm. = Eur. Commun. Dis. Bull. – volume: 28 start-page: e1987 year: 2018 ident: ref_31 article-title: Diversity of hepatitis E virus genotype 3 publication-title: Rev. Med. Virol. doi: 10.1002/rmv.1987 – volume: 101 start-page: 692 year: 2020 ident: ref_30 article-title: Update: Proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A) publication-title: J. Gen. Virol. doi: 10.1099/jgv.0.001435 – volume: 56 start-page: 2868 year: 2016 ident: ref_49 article-title: Hepatitis E virus infection in the Irish blood donor population publication-title: Transfusion doi: 10.1111/trf.13757 – volume: 123 start-page: 796 year: 2014 ident: ref_14 article-title: Hepatitis E transmission by transfusion of Intercept blood system-treated plasma publication-title: Blood doi: 10.1182/blood-2013-09-524348 – volume: 50 start-page: 2708 year: 2012 ident: ref_41 article-title: Novel approach for detection of hepatitis E virus infection in German blood donors publication-title: J. Clin. Microbiol. doi: 10.1128/JCM.01119-12 – volume: 58 start-page: 509 year: 2013 ident: ref_6 article-title: The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period publication-title: J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. doi: 10.1016/j.jcv.2013.08.022 – volume: 28 start-page: 1805 year: 2022 ident: ref_46 article-title: Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid2809.220487 – volume: 59 start-page: 612 year: 2019 ident: ref_48 article-title: Hepatitis E virus blood donor NAT screening: As much as possible or as much as needed? publication-title: Transfusion doi: 10.1111/trf.15058 |
| SSID | ssj0066907 |
| Score | 2.3711083 |
| Snippet | Introduction: Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting... Hepatitis E virus (HEV) genotype 3 is the major cause of acute viral hepatitis in several European countries. It is acquired mainly by ingesting contaminated... |
| SourceID | doaj proquest gale pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 744 |
| SubjectTerms | Adolescent Adult Aged Analysis Apheresis blood Blood & organ donations Blood banks Blood donors Blood Donors - statistics & numerical data Blood products Blood transfusion Blood transfusions Care and treatment Diagnosis Distribution Europe Female females Genetic screening Genomes Genotype Genotype & phenotype Genotypes genotyping Guillain-Barre syndrome Health aspects Hepatitis Hepatitis Antibodies - blood Hepatitis E - epidemiology Hepatitis E - transmission Hepatitis E - virology Hepatitis E virus Hepatitis E virus - classification Hepatitis E virus - genetics Hepatitis E virus - immunology Hepatitis E virus - isolation & purification hepatitis E virus phylogenetic analysis Humans immunity Immunoglobulin G Immunoglobulin G - blood Immunoglobulin M Immunoglobulin M - blood Infections Male Middle Aged Orthohepevirus A pork Prevalence Ribonucleic acid RNA RNA, Viral - blood RNA, Viral - genetics Seroconversion Serology subgenotype surveillance Switzerland Switzerland - epidemiology universal blood donor screening genotype viral hepatitis Viral Load Waterborne infections Young Adult zoonotic infection |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggNRLeZdAQQYhwSWq40ccn9AWWpVLVfFSb5HtxGilKmmT3aLe-A_8Q34JM4k3aAH1wilSMonszMPfeMYzhLxURe4Rl6dOOZZKZ1TqQhBprp1m1vGKsbHZhD46Kk5OzHHccOtjWuXKJg6Gumo97pHvglwabXiu5Zuz8xS7RmF0NbbQuE5uYJUEMaTuHa8scY6e31hNSIBrv3uRAXaHJVOurUFDqf6_DfIfMHNYbg5u_-9A75CtCDTpbJSMu-Ra3dwjt8bWk5f3yQes3WSHE0e0DXTml4uaHtaYX72Y93Sffpl3y56-j7laTU_nDf34DdhE9zDXnb5rm7brKazsxc_vPzjgwQfk88H-p7eHaeyvkHqASYu04EZqXQmvjDIyC4DdeGUsgjZhmbJZFQS3UtUhWG9kpbTA9lYASoJzQQfxkGw0bVM_ItSpwItMWyeDknnFnHaMewbOSmBZzYqEvF798dLH4uPYA-O0BCcEmVNOzEnIi4n0bKy48S-iPWTbRIBFsocbbfe1jDpXCh28cF55p7msMgGXmoPmWOa9FiFLyCtkeomqDIPxNp5IgClhUaxypvHUL4ZmE7KzRgkq6Ncfr0ShjCagL3_LQUKeT4_xTUxra-p2iTQ5RmqlVFfQgFznGF2G72yPIjlNWxRgXsGDfXz1AJ6QTRADOeZp7pCNRbesn5Kb_gIEqns26Mwvjwwcfw priority: 102 providerName: ProQuest |
| Title | Prevalence of Acute Hepatitis E Virus Infections in Swiss Blood Donors 2018–2020 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38793625 https://www.proquest.com/docview/3059792674 https://www.proquest.com/docview/3060381445 https://www.proquest.com/docview/3153630274 https://doaj.org/article/37fc3bc5cb724d13b72e2eada0cc73f1 |
| Volume | 16 |
| WOSCitedRecordID | wos001231315700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1999-4915 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0066907 issn: 1999-4915 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaggNRLxbtbysogJLhEdfyIk-MubNUeWEXloeUU2U4srYSSarPbihv_gX_IL2EmzkYsILhwSSR7EtkzHs838niGkBcqTRzi8sgqyyJpMxVZ70WUaKuZsbxkLBSb0PN5ulhk-U-lvjAmLKQHDow7Edo7YZ1yVnNZxgJeFYfpG-acFr5zfAD1bJ2psAcn6POFPEICnPqTqxhQOxhLuWN9uiT9v2_FvwDMztCc3iUHPUKkkzCye-RGVd8nd0LNyC8PyAUmXTLdVSHaeDpxm3VFzyoMjF4vWzqjH5erTUvP-yCruqXLmr67Bv7SKQap0zdN3axaCiY5_f71Gwcg95B8OJ29f30W9YURIgf4Zh2lPJNal8KpTGUy9gC6eJkZRFvCMGXi0gtupKq8Ny6TpdIC61IBmvDWeu3FI7JXN3V1SKhVnqexNlZ6JZOSWW0Zdwy8DM_iiqUj8mrLsML1WcOxeMXnArwH5G0x8HZEng-klyFVxp-Ipsj1gQCzW3cNIPOil3nxL5mPyEuUWYE6CINxpr9KAFPCbFbFRON1XTxTHZHjHUrQHbfbvZV60etuW8AOmOmMJxoG-2zoxi8xHq2umg3SJHjEKqX6Cw0YkwSPheE_j8OKGqYtUtgXwfU8-h_seEL2YbHIEIZ5TPbWq031lNx2V7DsVmNyUy9090zH5NZ0Ns8vxp2yjDHONYe2_Pxt_ukHvzMVyA |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFH4qUxBc2JeBAgaB4BLV8RInB4SmtFVHbUcjKKicQuzEaCSUlFla9cZ_4H_wo_glvDdJBg2g3nrgFCl5sez481vyNoBnOo4c6eWB1ZYHyiY6sN7LIDLW8MyKnPO62YQZDOLDw2S4Aj_aXBgKq2x54pxR55Wjf-TriMvEJCIy6vXR14C6RpF3tW2hUcNitzg9QZNt8qq_ifv7XIjtrYM3O0HTVSBwqBxMg1gkyphcOp3oRIUeNRaRJxmpKjLjOgtzL0WmdOF95hKVayOpqROKYm-tN17iuBdgVSHY4w6sDvv7w48t74_I1qzrF0mZ8PXjEK0FFNJqSerNmwP8LQL-UGznAm772v_2aa7D1UaVZr0a-zdgpShvwqW6uebpLXhL1amyeU4Vqzzrudm0YDsFRZBPRxO2xT6MxrMJ6zfRaOWEjUr27gSByDYomp9tVmU1njDUXeKf374L1Hhvw_tzWdAd6JRVWdwDZrUXcWgyq7xWUc6tsVw4juaY52HB4y68bHc4dU15dery8SVFM4vAkC7A0IWnC9KjuqbIv4g2CCYLAioDPr9RjT-nDVdJpfFOWqedNULlocRLIZA3ZNw5I33YhRcEspSYFU7GZU3OBS6Jyn6lPUN5zeR87sLaEiUyGbf8uIVe2jC5Sfobd114snhMb1LgXllUM6KJyBetlD6DBqVuRP5zHOdufQQWy5YxChC00e-fPYHHcHnnYH8v3esPdh_AFYSEqqNS16AzHc-Kh3DRHSO4xo-aE8vg03mfhF9PBXjz |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKgYoL-xIoYBAILtE4XuLkgNCU6aijotGITb2F2ImrkVBSkplWvfEf-Df8HH4J72UZNIB664FTpOTFsuPPb8nbCHmmotCiXu4bZZgvTax845zwQ200Sw3PGGubTejpNDo4iGcb5EefC4NhlT1PbBh1Vlr8Rz4AXMY65qGWA9eFRcxG49dHX33sIIWe1r6dRguR_fz0BMy3-tVkBHv9nPPx7oc3e37XYcC3oCgs_IjHUutMWBWrWAYOtBeexSmqLSJlKg0yJ3gqVe5camOZKS2wwROIZWeM007AuBfIRY1Fy5uwwVkvBUK0OttKRkLEbHAcgN0A4lquyb-mTcDfwuAPFbcRdeNr__NHuk6udgo2HbYn4gbZyIub5HLbcvP0FnmHNavSJtOKlo4O7XKR070c48oX85ru0k_zalnTSRejVtR0XtD3JwBPuoMx_nRUFmVVU9Boop_fvnPQg2-Tj-eyoDtksyiL_B6hRjkeBTo10ikZZsxow7hlYKQ5FuQs8sjLfrcT2xVdx94fXxIwvhAYyQoYHnm6Ij1qK438i2gHIbMiwOLgzY2yOkw6XpMI7awwVlmjucwCAZecA8dImbVauMAjLxBwCbIwmIxNu0wMWBIWA0uGGrOd0SXtke01SmA9dv1xD8OkY3118huDHnmyeoxvYjhfkZdLpAnRQy2lOoMGZHGIXnUY5257HFbLFhGIFbDc7589gcdkC-CfvJ1M9x-QK4AI2YaqbpPNRbXMH5JL9hiwVT1qji4ln8_7GPwC9_uAMg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Acute+Hepatitis+E+Virus+Infections+in+Swiss+Blood+Donors+2018%E2%80%932020&rft.jtitle=Viruses&rft.au=Niederhauser%2C+Christoph&rft.au=Gowland%2C+Peter&rft.au=Widmer%2C+Nadja&rft.au=Amar+EL+Dusouqui%2C+Soraya&rft.date=2024-05-01&rft.issn=1999-4915&rft.eissn=1999-4915&rft.volume=16&rft.issue=5&rft.spage=744&rft_id=info:doi/10.3390%2Fv16050744&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_v16050744 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon |